The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month.
May 23, 2011
not rated yet
0
US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.
May 14, 2011
not rated yet
2
According to new data presented today at the International Liver Congress, the United States (U.S.) could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease (NAFLD)1, one of the major contributing factors of ...
Apr 02, 2011
not rated yet
0
Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients. The new study identifies 15 genetic regions ...
Mar 13, 2011
not rated yet
0
| 
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third ...
Feb 24, 2011
not rated yet
0
A research team from South Korea investigated the current seroprevalence of hepatitis A virus (HAV) antibodies in patients with chronic viral liver disease in Korea. They found that most Korean patients with chronic liver ...
Jan 25, 2011
not rated yet
0
In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic ...
Dec 20, 2010
4.6 / 5 (5)
0
|
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of ...
Dec 01, 2010
4 / 5 (1)
0
The first entire genome of an Irish individual has been sequenced. The sequence is reported in BioMed Central's open access journal, Genome Biology and provides insight into the evolutionary history of this distinct lineag ...
Sep 07, 2010
not rated yet
1
Many diagnostic and treatment options have been developed for chronic liver disease during the last 40 years, yet their influence on survival remain unclear. A new study of the prognosis for patients hospitalized for liver ...
Aug 24, 2010
not rated yet
0
A prototype vaccine devised and tested in China has proven 100-percent effective in preventing hepatitis E, a disease that is widespread in the developing world and can be fatal, investigators reported in The Lancet on Mon ...
Aug 23, 2010
5 / 5 (4)
1
(PhysOrg.com) -- Investigators at Northwestern University Feinberg School of Medicine have identified the molecule Egr-1 (early growth response factor 1) as a new therapy target for scleroderma, an autoimmune disease for ...
Jun 14, 2010
4 / 5 (1)
0
In the May issue of Mayo Clinic Proceedings, physician experts review current practices for pain management in cirrhotic patients. The physician experts reviewed all current literature available on PubMed and MEDLINE with n ...
May 26, 2010
not rated yet
0
Fatal assaults among the most disadvantaged in Scotland are more than 30 times as high as they are among the most affluent sectors of society, reveals research published today in the Journal of Epidemiology and Community He ...
May 05, 2010
5 / 5 (1)
1
A widely and safely used plant extract acts as a novel anti-inflammatory agent that may one day be used for the treatment of chronic obstructive pulmonary disease, or COPD, as well as other inflammatory conditions. There ...
May 03, 2010
5 / 5 (2)
1
